Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review

Pharmacotherapy
Allison Beck Blackmer, James A Feinstein

Abstract

Neurodevelopmental disorders (NDDs) are defined as a group of disorders caused by changes in early brain development, resulting in behavioral and cognitive alterations in sensory and motor systems, speech, and language. NDDs affect approximately 1-2% of the general population. Up to 80% of children with NDDs are reported to have disrupted sleep; subsequent deleterious effects on daytime behaviors, cognition, growth, and overall development of the child are commonly reported. Examples of NDDs discussed in this review include autism spectrum disorder, cerebral palsy, Rett syndrome, Angelman syndrome, Williams syndrome, and Smith-Magenis syndrome. The etiology of sleep disorders in children with NDDs is largely heterogeneous and disease specific. The diagnosis and management of sleep disorders in this population are complex, and little high-quality data exist to guide a consistent approach to therapy. Managing sleep disorders in children with NDDs is critical both for the child and for the family but is often frustrating due to the refractory nature of the problem. Sleep hygiene must be implemented as first-line therapy; if sleep hygiene alone fails, it should be combined with pharmacologic management. The available evidence for t...Continue Reading

References

May 5, 1998·Developmental Medicine and Child Neurology·A J McArthur, S S Budden
Nov 20, 1998·The Journal of Pediatrics·R ArensP Kaplan
Jan 5, 2002·Seminars in Pediatric Neurology·G Stores
Oct 24, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Germaine CornélissenKuniaki Otsuka
Mar 10, 2005·European Child & Adolescent Psychiatry·Antonina Ingrassia, Jeremy Turk
Sep 27, 2005·The Journal of Pediatrics·Michael R PranzatelliAmy E Oksa
Jul 5, 2006·Archives of Pediatrics & Adolescent Medicine·Dan MerensteinHaya R Rubin
Aug 31, 2006·The Journal of Pediatrics·Rosario CarpizoEmilio J Sánchez-Barceló
Oct 31, 2006·Journal of Child and Adolescent Psychopharmacology·Kimberly A StiglerChristopher J McDougle
Mar 14, 2007·Pediatric Neurology·Cara F DosmanS Wendy Roberts
Sep 4, 2007·Sleep Medicine·Karine PelcBernard Dan
Nov 23, 2007·Sleep Medicine·Robert Y Moore
Feb 19, 2008·Brain & Development·Xue MingGeorge C Wagner
Jun 10, 2008·Journal of Child Neurology·Wiebe BraamLeopold M G Curfs
Dec 3, 2008·Pediatrics·James E JanOsman S Ipsiroglu
Feb 12, 2009·European Child & Adolescent Psychiatry·Samuele CorteseMichel Lecendreux
Nov 1, 2007·Current Genomics·K M J van Loo, G J M Martens
Jul 14, 2010·Sleep Medicine·Judith A OwensHal L Kirchner
Aug 10, 2010·Neuroscience Letters·William H RodenLaura A Jansen
Oct 14, 2010·Research in Developmental Disabilities·Dagmara AnnazAnnette Karmiloff-Smith
Dec 7, 2010·Journal of Intellectual Disability Research : JIDR·F GombosI Kovács
May 24, 2011·Pediatric Clinics of North America·Judith A Owens, Jodi A Mindell
Jun 15, 2011·Journal of Child Neurology·Elisabeth Simard-TremblayMichael Shevell
Jul 9, 2011·American Journal of Medical Genetics. Part a·Philip M BooneLorraine Potocki
Sep 17, 2011·Current Opinion in Pulmonary Medicine·Judith A Owens
Sep 24, 2011·Sleep Medicine·Thornton B A MasonAllan I Pack
Nov 3, 2011·Journal of Intellectual Disability Research : JIDR·S E GoldmanB A Malow
Sep 12, 2012·Pediatric Neurology·Suresh Kotagal, Eileen Broomall
Nov 1, 2012·Journal of Child Neurology·Althea A Robinson, Beth A Malow
Aug 22, 2013·Current Psychiatry Reports·Brenda Bursch, Marcy Forgey
Sep 24, 2013·Paediatric Respiratory Reviews·Kenneth Nunn
Sep 24, 2013·Current Opinion in Pulmonary Medicine·Madeleine Grigg-Damberger, Frank Ralls
Jan 1, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Justina M DamianiPamela Sohoni
Apr 11, 2014·Journal of Clinical Psychopharmacology·Mizuki AsanoYuji Wada
Apr 23, 2014·Journal of Autism and Developmental Disorders·Suzanne E GoldmanBeth A Malow
Jun 6, 2015·Current Sleep Medicine Reports·Olivia J VeatchBeth A Malow
Aug 2, 2015·Pediatric Neurology·Rebecca LaneBarbara Felt

❮ Previous
Next ❯

Citations

Jun 4, 2016·American Journal of Medical Genetics. Part a·Sharolin BobanHelen Leonard
Oct 30, 2016·Postgraduate Medicine·Hani Raoul Khouzam
Oct 5, 2017·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Ana Hanlon-DearmanHeather Carmichael Olson
Sep 13, 2017·Children·Laura Beth Mann DosierZheng Fan
Mar 3, 2018·Children·Katherine E NelsonChris Feudtner
Feb 13, 2018·Continuum : Lifelong Learning in Neurology·Kiran Maski, Judith Owens
Mar 25, 2018·Pediatric Dermatology·Devika PatelTor Shwayder
Sep 16, 2017·Journal of Child Neurology·Ana Checa-RosMaría Del Carmen Augustín-Morales
Jan 31, 2018·International Journal of Endocrinology·Justyna PaprockaMaria Sokół
Oct 9, 2018·Journal of Paediatrics and Child Health·Helen S Heussler, Harriet Hiscock
Sep 15, 2018·Endocrine Reviews·José Cipolla-Neto, Fernanda Gaspar do Amaral
Dec 7, 2019·CPT: Pharmacometrics & Systems Pharmacology·Laura OggianuSerena Tongiani
Sep 25, 2017·Journal of Developmental and Behavioral Pediatrics : JDBP·Marilee A MartensDaniel L Coury
Feb 6, 2020·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Emily HanzlikJessica Duis
Jun 13, 2020·Disability and Rehabilitation·Raquel Y HulstOlaf Verschuren
Sep 3, 2020·Journal of Child Neurology·Stephanie R KellerFlorian S Eichler
Apr 18, 2017·PloS One·Mihaela FriciuGrégoire Leclair
Apr 9, 2019·BMJ Paediatrics Open·Aoife McDonald, Desaline Joseph
Jul 25, 2020·Child: Care, Health and Development·Raquel Y HulstOlaf Verschuren
Jul 8, 2020·International Journal of Molecular Sciences·Ann Genovese, Merlin G Butler
Jun 9, 2020·American Journal of Medical Genetics. Part a·Joseph A PereiraChristopher J Keary
Jun 23, 2016·Clinical Medicine Insights. Pediatrics·Richard E Frye, Daniel A Rossignol
Mar 16, 2019·Journal of Translational Medicine·Susanna EspositoElisabetta Mencaroni
Oct 23, 2019·Expert Opinion on Pharmacotherapy·Oliviero BruniRaffaele Ferri
Jul 24, 2020·European Child & Adolescent Psychiatry·Elin E KimlandAnastasia N Iliadou
Nov 20, 2016·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Wen-Hann Tan, Lynne M Bird
Nov 22, 2020·Journal of Neurodevelopmental Disorders·Caroline Greiner de MagalhãesCarolyn B Mervis
Dec 12, 2020·JAMA Network Open·Abigail Musial, Joanna E Thomson
Dec 22, 2020·Review Journal of Autism and Developmental Disorders·Dana Kamara, Theodore P Beauchaine
Feb 8, 2021·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Stephanie N HosleyDeborah Steward
Mar 20, 2021·Frontiers in Pediatrics·Elizabeth J HalsteadDagmara Dimitriou
Apr 16, 2021·Progress in Neuro-psychopharmacology & Biological Psychiatry·Antonio M PersicoCelso Arango
May 5, 2021·Acta Paediatrica·Zunera ZareenEleanor J Molloy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Autism: Treatment Targets

The absence of effective treatments for autism are due to the high clinical and genetic heterogeneity between affected individuals, restricted knowledge of the underlying pathophysiological mechanisms, and the lack of reliable diagnostic biomarkers. Identification of more homogenous biological subgroups is therefore essential for the development of novel treatments based on the molecular mechanisms underpinning autism and autism spectrum disorders. Find the latest research on autism treatment targets here.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Justina M DamianiPamela Sohoni
Current Treatment Options in Neurology
Kyle P Johnson, Beth A Malow
Current Opinion in Pediatrics
Kiran P MaskiSarah J Spence
© 2022 Meta ULC. All rights reserved